COMMUNIQUÉS West-GlobeNewswire

Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024

17/10/2024 - 09:00

XVR013m, a broadly neutralizing VHH-FC antibody consistently shows exceptional neutralization potency across both SARS-CoV-2 pre-Omicron and Omicron variants GHENT, Belgium, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio [...]

Finnish municipality has chosen Aino

17/10/2024 - 08:30

Yet another Finnish municipality, Siilinjärvi, has chosen Aino’s SaaS platform to be more socially sustainable and to achieve the operational goals with the existing staff. The agreement includes a total of 850 [...]

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

17/10/2024 - 07:30

Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Topline results from the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial expected in Q3 2025 Cash of €19.7 million [...]

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

17/10/2024 - 07:30

Communiqué de presse Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Premiers résultats de l'étude clinique de phase 3 NCX 470 (bimatoprost grenod) attendus au [...]

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

17/10/2024 - 07:30

Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in [...]

Communiqué de presse : Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération

17/10/2024 - 07:30

Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération Paris, le 17 octobre 2024. Sanofi et Orano Med, une filiale du groupe Orano à la pointe du [...]

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

17/10/2024 - 07:30

Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in [...]

Communiqué de presse : Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération

17/10/2024 - 07:30

Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération Paris, le 17 octobre 2024. Sanofi et Orano Med, une filiale du groupe Orano à la pointe du [...]

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.

16/10/2024 - 23:15

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of [...]

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

16/10/2024 - 22:35

SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer [...]

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

16/10/2024 - 22:35

-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments THE WOODLANDS, Texas, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. ( [...]

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

16/10/2024 - 22:30

Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management GERMANTOWN, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American [...]

Teladoc Health to Announce Third Quarter 2024 Financial Results

16/10/2024 - 22:30

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024 [...]

Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality

16/10/2024 - 22:30

WARREN, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

16/10/2024 - 22:17

SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]

Ezra, Full-Body MRI Leader, Launches AI-Powered Scans to Philadelphia in Partnership with Princeton Radiology

16/10/2024 - 22:17

Healthcare startup brings early cancer detection technology to Pennsylvania for the first time NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Ezra , the company revolutionizing early cancer detection through full-body MRI [...]

Certara Appoints John Reynders as New Independent Board Member

16/10/2024 - 22:15

RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of John Reynders, PhD, to its Board of Directors, [...]

Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer

16/10/2024 - 22:15

– Mr. Tamberrino and Profound’s CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 – – Appointment comes as Profound continues to make final preparations for the permanent [...]

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles

16/10/2024 - 22:15

IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp . (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD [...]